The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Molecular testing prior to first-line therapy in patients with stage IV nonsquamous non-small cell lung cancer (NSCLC): A survey of U.S. medical oncologists.
Mark R. Green
No relevant relationships to disclose
Joanne Willey
No relevant relationships to disclose
Arden Buettner
No relevant relationships to disclose
Maria Lankford
No relevant relationships to disclose
Doug B. Neely
No relevant relationships to disclose
Suresh S. Ramalingam
No relevant relationships to disclose